Stock data
Tyra Biosciences, Inc. (TYRA)
Tyra Biosciences, Inc. (TYRA) reported net income of -US$119.95M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$132.76M | -US$119.95M | — |
| 2024 | — | — | -US$104.18M | -US$86.48M | — |
| 2023 | — | — | -US$79.94M | -US$69.13M | — |
| 2022 | — | — | -US$58.93M | -US$55.33M | — |
| 2021 | — | — | -US$26.29M | -US$26.29M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$45.56M | — |
| 2026-03-31 | — | -US$39.30M | — |
| 2025-12-31 | — | -US$33.83M | — |
| 2025-09-30 | — | -US$29.87M | — |
| 2025-06-30 | — | -US$28.10M | — |
| 2025-03-31 | — | -US$28.15M | — |
| 2024-12-31 | — | -US$25.57M | — |
| 2024-09-30 | — | -US$24.02M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.